Lynas Rare Earths Limited (LON:0A2N)
15.29
+0.03 (0.21%)
At close: Oct 31, 2025
Lynas Rare Earths Revenue
In the fiscal year ending June 30, 2025, Lynas Rare Earths had annual revenue of 556.51M AUD with 20.12% growth. Lynas Rare Earths had revenue of 302.20M in the half year ending June 30, 2025, a decrease of -18.17%.
Revenue
556.51M AUD
Revenue Growth
+20.12%
P/S Ratio
26.33
Revenue / Employee
11.84M AUD
Employees
47
Market Cap
7.01B GBP
Revenue Chart
* This company reports financials in AUD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 556.51M | 93.23M | 20.12% |
| Jun 30, 2024 | 463.29M | -275.99M | -37.33% |
| Jun 30, 2023 | 739.28M | -180.74M | -19.64% |
| Jun 30, 2022 | 920.01M | 430.99M | 88.13% |
| Jun 30, 2021 | 489.02M | 183.91M | 60.28% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shell | 200.18B |
| BP p.l.c. | 134.89B |
| Unilever | 51.24B |
| HSBC Holdings | 43.13B |
| AstraZeneca | 41.24B |
| Rio Tinto Group | 39.22B |
| GSK plc | 32.17B |
| British American Tobacco p.l.c. | 25.60B |